Literature DB >> 8407982

Apolipoprotein A-I domains involved in lecithin-cholesterol acyltransferase activation. Structure:function relationships.

M Sorci-Thomas1, M W Kearns, J P Lee.   

Abstract

A series of mutant apolipoprotein (apoA-I) constructs were designed and then expressed in cell culture to identify structural domains within the mature native apoA-I protein that participate in the activation of the plasma enzyme, lecithin-cholesterol acyltransferase (LCAT). Evolutionary conservation analysis has shown previously that apoA-I contains eight repeats containing 22 amino acids and two repeats containing 11 amino acids that are highly conserved among species as well as within the apolipoprotein supergene family. These tandem repeats begin at residue 44 and are usually marked by a proline residue, with six of the 22-mer repeats showing high amphipathic alpha-helical character. To determine if specific 11- or 22-amino acid domains are essential for maximal LCAT activation within the entire native protein, each of the 10 repeats was sequentially deleted using a polymerase chain reaction based method of mutagenesis. The wild-type and mutant apoA-I gene constructs were expressed in Chinese hamster ovary (CHO) cells and stable lines established. Wild-type and mutant apoA-I protein were purified from 48-96-h conditioned serum-free medium and characterized by SDS-polyacrylamide gel electrophoresis and Western blot analysis. Wild-type apoA-I showed a single migrating band of 28,000 daltons that corresponded to the mobility of human plasma apoA-I, whereas apoA-I deletion mutants (lacking 22- or 11-mer repeats) showed the corresponding shift to lower molecular size. To measure the relative LCAT activation of all deletion mutant apoA-I proteins relative to wild-type apoA-I, an assay system utilizing small unilamellar vesicles as the lipid substrate was used. The results of these studies suggest that several central amphipathic alpha-helical regions within the mature protein are critical in LCAT activation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8407982

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  25 in total

1.  Dysfunctional HDL containing L159R ApoA-I leads to exacerbation of atherosclerosis in hyperlipidemic mice.

Authors:  Mary G Sorci-Thomas; Manal Zabalawi; Manish S Bharadwaj; Ashley J Wilhelm; John S Owen; Bela F Asztalos; Shaila Bhat; Michael J Thomas
Journal:  Biochim Biophys Acta       Date:  2011-09-14

2.  Crystallization and preliminary X-ray diffraction analysis of apolipoprotein E-containing lipoprotein particles.

Authors:  Yvonne Newhouse; Clare Peters-Libeu; Karl H Weisgraber
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2005-10-20

Review 3.  Three-dimensional models of HDL apoA-I: implications for its assembly and function.

Authors:  Michael J Thomas; Shaila Bhat; Mary G Sorci-Thomas
Journal:  J Lipid Res       Date:  2008-05-30       Impact factor: 5.922

4.  The interplay between size, morphology, stability, and functionality of high-density lipoprotein subclasses.

Authors:  Giorgio Cavigiolio; Baohai Shao; Ethan G Geier; Gang Ren; Jay W Heinecke; Michael N Oda
Journal:  Biochemistry       Date:  2008-03-27       Impact factor: 3.162

Review 5.  Lipid-free Apolipoprotein A-I Structure: Insights into HDL Formation and Atherosclerosis Development.

Authors:  Xiaohu Mei; David Atkinson
Journal:  Arch Med Res       Date:  2015-06-03       Impact factor: 2.235

6.  A thumbwheel mechanism for APOA1 activation of LCAT activity in HDL.

Authors:  Allison L Cooke; Jamie Morris; John T Melchior; Scott E Street; W Gray Jerome; Rong Huang; Andrew B Herr; Loren E Smith; Jere P Segrest; Alan T Remaley; Amy S Shah; Thomas B Thompson; W Sean Davidson
Journal:  J Lipid Res       Date:  2018-05-17       Impact factor: 5.922

7.  Conformation of dimeric apolipoprotein A-I milano on recombinant lipoprotein particles.

Authors:  Shaila Bhat; Mary G Sorci-Thomas; Laura Calabresi; Michael P Samuel; Michael J Thomas
Journal:  Biochemistry       Date:  2010-06-29       Impact factor: 3.162

8.  Phospholipid Component Defines Pharmacokinetic and Pharmacodynamic Properties of Synthetic High-Density Lipoproteins.

Authors:  Maria V Fawaz; Sang Yeop Kim; Dan Li; Ran Ming; Ziyun Xia; Karl Olsen; Irina D Pogozheva; John J G Tesmer; Anna Schwendeman
Journal:  J Pharmacol Exp Ther       Date:  2019-11-27       Impact factor: 4.030

9.  Arginine 123 of apolipoprotein A-I is essential for lecithin:cholesterol acyltransferase activity.

Authors:  Irina N Gorshkova; Xiaohu Mei; David Atkinson
Journal:  J Lipid Res       Date:  2017-12-05       Impact factor: 5.922

10.  Predicting the structure of apolipoprotein A-I in reconstituted high-density lipoprotein disks.

Authors:  J C Phillips; W Wriggers; Z Li; A Jonas; K Schulten
Journal:  Biophys J       Date:  1997-11       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.